Stock Detail
LUMINEX CORPORATION
Sector: Medical Instruments Supls
Latest Quote @ Wed Jun 6 21:25:08 (15 min delayed)
| N/A |
N/A |
$20.39 |
-0.39 |
-1.88% |
|
Last Day's Data
| $20.78 |
$20.84 |
$0.80 |
4.00% |
0.00 |
$19.98 |
| $20.00 |
$20.00 |
135,505.00 |
856.26M |
168,355.00 |
134.51 |
Pivot Table
| R2 |
R1 |
Pivot |
S1 |
S2 |
| 21.38 |
21.08 |
20.54 |
20.24 |
19.70 |
Stock Profile
Luminex Corporation engages in the design, development, manufacture, and marketing of proprietary biological testing technologies with applications throughout the life sciences industry. The company's xMAP technology enables its Luminex 100 System to simultaneously perform up to 100 bioassays on a single drop of fluid by reading biological tests that are taking place on the surface of microscopic polystyrene beads called microspheres. The xMAP technology is used in various segments of the life sciences industry, including the fields of drug discovery and development, clinical diagnostics, genetic analysis, protein analysis, and biomedical research. The company's customers include clinical diagnostic, pharmaceutical, biotechnological, and chemical companies. Luminex Corp. has an agreement with Biohit Oyj for the development and commercialisation of a diagnostic test system segment. The company was incorporated in 1995 and is based in Austin, Texas.
